Parkinson's In the News

September 2011 Monthly Message

Sleep Disorder is Risk Factor for Parkinson’s
A new European study suggests individuals suffering from REM sleep behavior disorders have an increased risk of developing Parkinson’s disease (PD). More…

Study Suggests Seeing a Neurologist Helps People with Parkinson’s Live Longer
People with Parkinson’s disease who go to a neurologist for their care are more likely to live longer, less likely to be placed in a nursing home and less likely to break a hip than people who go to a primary care physician, according to a study published in the August 10, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology (AAN). More…

NIH Blueprint empowers drug development for nervous system disorders
National Institute of Neurological Disorders and Stroke
The National Institutes of Health has made awards to investigators across the United States for an ambitious set of projects seeking to develop new drugs for disorders of the nervous system. The projects – aimed at treating conditions such as vision loss, neurodegenerative disease and depression – are funded through the NIH Blueprint for Neuroscience Research.  The NIH Blueprint pulls together 15 of the agency's institutes and centers, leveraging their resources to confront major, cross-cutting challenges in neuroscience research. The Blueprint Neurotherapeutics Network will serve as a resource enabling investigators to develop new drugs for nervous system disorders and prepare them for clinical trials, and will be funded at up to $50 million over five years. More…

Traumatic Brain Injury May Increase Parkinson’s Risk
Traumatic brain injuries are known to trigger a variety of symptoms ranging from a simple headache to permanent memory and thinking problems.  Now scientists at UCLA have discovered that a traumatic brain injury can result in the loss of a specific type of neuron, elevating the risk for Parkinson’s disease as well. More…

Protein linked to Parkinson’s disease may regulate fat metabolism
National Institutes of Health
National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson’s disease, regulates how cells in our bodies take up and process dietary fats. Parkinson’s disease is a complex, progressive, and currently incurable neurological disorder characterized by shaking, stiffness, slowed movement, and impaired balance. Parkinson’s primarily affects people over 50, but in about 5 to10 percent of cases it occurs in people as young as their 20s. This form of the disease, which affects actor, author, and Parkinson’s activist Michael J. Fox, is known as early-onset Parkinson’s. More…

Do Generic and Branded Medicines for the Treatment of Parkinson’s Disease Have Equal Effectiveness?
WeMove News
Dr. Go from the University of Florida’s McKnight Brain Institute and physicians from this and other institutions reviewed the results of studies that have compared the effectiveness of generic versus brand-name drugs in the treatment of Parkinson’s disease (PD) and looked into potential reasons for differences. More…